SEC 13F Intelligence

Mass General Brigham, Inc / TNGX

Mass General Brigham, Inc’s Tango Therapeutics Inc Position

Does Mass General Brigham, Inc own Tango Therapeutics Inc (TNGX)? Yes — 354.2K shares worth $7M (+1.58% of its 13F portfolio) as of Q1 2026.

Position Value
$7M
Q1 2026
Shares
354.2K
% of Portfolio
+1.58%
Quarters Held
5
currently held

Position History TNGX

Reported value by quarter
Q1 ’24: $3MQ1 ’24Q2 ’24: $3MQ2 ’24Q3 ’24: $3MQ3 ’24Q4 ’25: $3MQ4 ’25Q1 ’26: $7MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026354.2K$7M+1.58%
Q4 2025354.2K$3M+0.39%
Q3 2024354.2K$3M+6.25%
Q2 2024354.2K$3M+14.79%
Q1 2024354.2K$3M+4.92%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mass General Brigham, Inc’s full portfolio or all institutional holders of TNGX.